Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12351
PUT
Caribou Biosciences
CRBU
$189M
| $18K | ﹤0.01% |
14,300
-15,000
| -51% | -$14.8K |
|
12352
PDS Biotechnology
PDSB
$12.4M
| $17.8K | ﹤0.01% |
13,407
-12,346
| -48% | -$16.8K |
|
|
IMA
12353
ImageneBio Inc
IMA
$63M
| $17.6K | ﹤0.01% |
+1,095
| New | +$16.1K |
|
|
NAMMW
12354
Namib Minerals Warrants
NAMMW
$4.18M
| $17.4K | ﹤0.01% |
+89,128
| New | +$24.5K |
|
|
NEWP
12355
New Pacific Metals
NEWP
$1.31B
| $17.3K | ﹤0.01% |
12,934
-18,291
| -59% | -$23.1K |
|
12356
Sadot Group
SDOT
$23.8M
| $17.2K | ﹤0.01% |
65
-30
| -32% | -$9.4K |
|
12357
Magic Empire Global Ltd
MEGL
$5.92M
| $17.2K | ﹤0.01% |
+11,171
| New | +$15.9K |
|
|
ORGN
12358
CALL
DELISTED
Origin Materials
ORGN
| $17.2K | ﹤0.01% |
1,193
-1,894
| -61% | -$32.1K |
|
12359
PUT
Rackspace Technology
RXT
$867M
| $16.8K | ﹤0.01% |
13,100
-32,000
| -71% | -$41.7K |
|
|
PLG
12360
PUT
Platinum Group Metals
PLG
$203M
| $16.7K | ﹤0.01% |
10,900
-4,200
| -28% | -$5.63K |
|
12361
Grove Collaborative
GROV
$41.8M
| $16.5K | ﹤0.01% |
14,354
-14,533
| -50% | -$17.2K |
|
|
IRD
12362
Opus Genetics
IRD
$342M
| $16.3K | ﹤0.01% |
17,303
-5,796
| -25% | -$5.37K |
|
|
MNDR
12363
Mobile-health Network Solutions
MNDR
$1.92M
| $16K | ﹤0.01% |
+504
| New | +$21.3K |
|
12364
CALL
Hain Celestial
HAIN
$78.9M
| $16K | ﹤0.01% |
+10,500
| New | +$24.5K |
|
12365
Roadzen Inc Warrants
RDZNW
| $15.8K | ﹤0.01% |
309,514
-53,432
| -15% | -$2.92K |
|
|
TPIC
12366
CALL
DELISTED
TPI Composites
TPIC
| $15.7K | ﹤0.01% |
18,300
-220,200
| -92% | -$224K |
|
12367
CALL
Vista Gold
VGZ
$346M
| $15.3K | ﹤0.01% |
+15,600
| New | +$15.2K |
|
|
FRSX
12368
CALL
Foresight Autonomous Holdings
FRSX
$4.91M
| $15.2K | ﹤0.01% |
1,576
+466
| +42% | +$5.82K |
|
12369
GameSquare
GAME
$47.4M
| $14.9K | ﹤0.01% |
2,150
+308
| +17% | +$1.81K |
|
12370
PUT
Diana Shipping
DSX
$342M
| $14.9K | ﹤0.01% |
10,200
-13,400
| -57% | -$20.1K |
|
12371
Retractable Technologies
RVP
$22M
| $14.8K | ﹤0.01% |
23,184
-11,454
| -33% | -$7.97K |
|
12372
Apollomics Inc Warrant
APLMW
$1.32M
| $14.6K | ﹤0.01% |
+328,969
| New | +$5.49K |
|
12373
Workhorse Group
WKHS
$34.3M
| $14.5K | ﹤0.01% |
1,100
-310
| -22% | -$4.02K |
|
|
CYPH
12374
Cypherpunk Technologies Inc
CYPH
$177M
| $14.5K | ﹤0.01% |
48,770
-241,273
| -83% | -$87.8K |
|
12375
Destination XL Group
DXLG
$34.3M
| $14.3K | ﹤0.01% |
12,896
-108,665
| -89% | -$119K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.